Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
5.68
+0.31 (5.77%)
At close: May 12, 2025, 4:00 PM
5.80
+0.12 (2.11%)
After-hours: May 12, 2025, 7:08 PM EDT

Fulcrum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
307254417379717319
Upgrade
Market Cap Growth
-73.41%-39.25%10.13%-47.15%124.42%-14.89%
Upgrade
Enterprise Value
885172171477192
Upgrade
Last Close Price
5.684.706.757.2817.6911.71
Upgrade
PS Ratio
4.413.17148.7759.7537.4136.21
Upgrade
PB Ratio
1.341.041.771.913.393.36
Upgrade
P/TBV Ratio
1.341.041.771.913.393.36
Upgrade
EV/Sales Ratio
1.100.0761.2126.9924.8721.82
Upgrade
Debt / Equity Ratio
0.040.040.050.07-0
Upgrade
Asset Turnover
0.340.310.010.030.110.07
Upgrade
Quick Ratio
28.2922.1317.4412.2011.584.33
Upgrade
Current Ratio
28.7122.6317.7112.4111.774.47
Upgrade
Return on Equity (ROE)
-0.23%-4.07%-44.84%-53.53%-52.72%-77.68%
Upgrade
Return on Assets (ROA)
-2.74%-4.78%-28.56%-30.36%-27.79%-37.30%
Upgrade
Return on Capital (ROIC)
-2.83%-4.98%-30.18%-33.07%-33.03%-49.08%
Upgrade
Earnings Yield
-0.17%-3.84%-23.33%-28.99%-11.28%-22.17%
Upgrade
FCF Yield
2.47%-0.98%-21.92%-26.13%-11.19%-17.21%
Upgrade
Buyback Yield / Dilution
-0.38%-1.10%-36.27%-27.23%-39.47%-129.53%
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q